Outlook Therapeutics, Inc.
SEC CIK 1649989 · OTLK · last insider filing 2026-06-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Haddadin Yezan Munther | Director | filed 2017 - 2026 |
| Sukhtian Ghiath M. | Director | filed 2017 - 2026 |
| GMS Ventures & Investments | Director | filed 2020 - 2026 |
| Hilzinger Kurt J | Director | filed 2016 - 2026 |
| Thurman Randy H | Director | filed 2018 - 2026 |
| Sukhtian Faisal Ghiath | Director | filed 2017 - 2026 |
| Gangolli Julian S | Director | filed 2020 - 2025 |
| Auffarth Gerd | Director | filed 2020 - 2025 |
| Haller Julia A | Director | filed 2022 - 2025 |
| Huang Andong | Director | filed 2020 - 2025 |
| Kenyon Lawrence A | Director · Chief Financial Officer | filed 2016 - 2024 |
| Trenary C Russell III | Director · CEO and President | filed 2021 - 2024 |
| GMS Tenshi Holdings Pte. Ltd | Director · Chief Executive Officer | filed 2017 - 2022 |
| Pillai Arun Kumar | Director | filed 2017 - 2022 |
| Thomas Joe | Director | filed 2017 - 2019 |
| Mohan Pankaj | Director · President & CEO | filed 2016 - 2019 |
| Windisch Joerg | Director | filed 2018 - 2018 |
| Albrecht Claudio | Director | filed 2017 - 2017 |
| Canute Scott A | Director | filed 2016 - 2017 |
| Brady Todd C | Director | filed 2016 - 2017 |
| Dyrness Albert D. | Director | filed 2016 - 2017 |
| Smith Hoke Robin | Director | filed 2016 - 2016 |
| Griffith Donald J. | Director | filed 2016 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Jahr Robert Charles | Chief Executive Officer | filed 2025 - 2025 |
| Evanson Jeff | Chief Commercial Officer | filed 2018 - 2024 |
| Dagnon Terry | Chief Operations Officer | filed 2018 - 2023 |
| Bahrt Kenneth | Chief Medical Officer | filed 2016 - 2019 |
| Mcandrew Stephen J | SVP Bus. Strat. & Dev. | filed 2016 - 2018 |
| Yamashita Elizabeth A. | VP, Regulatory Affairs | filed 2016 - 2017 |
| Gangloff Scott A. | SVP, Development & Mfrg | filed 2016 - 2016 |
| Bao Kogan | VP, Analytical Sciences | filed 2016 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.